Vanguard Group Inc Novan, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.05 - $2.04 $43,785 - $85,068	41,700 Added 5.44%	807,993 $1.05 Million
Q4 2022 Feb 10, 2023	SELL	$0.82 - $1.48 $19,209 - $34,670	-23,426 Reduced 2.97%	766,293 $1.12 Million
Q1 2022 May 13, 2022	BUY	$2.95 - $4.41 $26,252 - $39,244	8,899 Added 1.14%	789,719 $3.11 Million
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.15 $3,836 - $7,758	-952 Reduced 0.12%	780,820 $3.26 Million
Q2 2021 Aug 13, 2021	BUY	$7.8 - $17.35 $6.1 Million - $13.6 Million	781,772 New	781,772 $7.86 Million

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.